Koyfin Home > Directory > Health Care > Akebia Therapeutics > EBIT

Akebia Therapeutics EBIT Chart (AKBA)

Akebia Therapeutics annual/quarterly EBIT from 2012 to 2020. Earnings before interest and taxes measures the profit a company generates from its operations, making it synonymous with operating profit. By ignoring tax and interest expenses, it focuses solely on a company's ability to generate earnings from operations, ignoring variables such as the tax burden and capital structure.
  • Akebia Therapeutics EBIT for the quarter ending June 06, 2020 was $-28m a -22.86% increase of 7m year over year
  • Akebia Therapeutics EBIT for the last 12 months ending June 06, 2020 was $-186m a -5.40% increase of 10m year over year
  • Akebia Therapeutics Annual EBIT for 2019 was $-209m a 28.00% decrease of -58m from 2018
  • Akebia Therapeutics Annual EBIT for 2018 was $-150m a 48.98% decrease of -74m from 2017
  • Akebia Therapeutics Annual EBIT for 2017 was $-77m a -77.97% increase of 60m from 2016
Other Income Statement Metrics:
  • Akebia Therapeutics EBITDA for the quarter ending December 12, 2018 was $-85m a 71.45% decrease of -61m year over year
  • Akebia Therapeutics Net Income for the quarter ending December 12, 2018 was $-88m a 73.50% decrease of -65m year over year
  • Akebia Therapeutics Total Revenue for the quarter ending December 12, 2018 was $60m a 23.26% increase of 14m year over year
View Chart On Koyfin

Quarterly AKBA EBIT Data

06/2020$-28m
03/2020$-48m
12/2019$-75m
09/2019$-35m
06/2019$-39m
03/2019$-61m
12/2018$-62m
09/2018$-28m
06/2018$-36m
03/2018$-24m

Annual AKBA EBIT Data

2019$-209m
2018$-150m
2017$-77m
2016$-136m
2015$-62m
2014$-38m
2013$-16m
2012$-9m
2011$-16m